News: Dexa Group

12 August 2022

The Ministry of Health Continues to Encourage the Use of Phytopharmaceuticals in Health Service Facilities

The government primarily focuses on developing phytopharmaceuticals to create a system of health resilience and domestic pharmaceutical self-reliance. Launching the Phytopharmaca Formulary and promoting its usage in medical institutions are examples of the government's commitment to fostering the use of phytopharmaceuticals. The Director General of Pharmaceuticals and Medical Devices at…
5 August 2022

Dexa Group's Commitment to Encourage the Production of Natural Medicine Raw Materials for National Independence

With more than 28000 plant species and 2,848 medicinal plants, Indonesia has the second-highest biodiversity in the world. Its natural resources hold tremendous promise for developing phytopharmaceuticals and herbal medicines, including Indonesia Indigenous Modern Medicine (IIMM). Penny K. Lukito, head of the Food and Drug Supervisory Agency (BPOM), stated that…
8 July 2022

Prevent Stunting, Dexa Group's Green Pharmacy Becomes The Partner of BKKBN

Indonesia's 29th National Family Day (Harganas) was celebrated with the theme "Let's Prevent Stunting for Stunting-Free Family". President Joko Widodo (Jokowi) said that the government had appointed the National Population and Family Planning Agency (BKKBN) to reduce the prevalence of stunting to 14% in 2024. Therefore, BKKBN collaborates with several…
6 July 2022

Mr. Ferry A. Soetikno as a Speaker at the Advisory Board Sharing Session #7: Drug Raw Material Independence as a Part of the Dynamics of the Indonesian Pharmaceutical Industry

The Covid-19 epidemic has given Indonesia's pharmaceutical sector a fresh start. In stark contrast to the average 5–10% growth rate, the pharmaceutical sector shrank by -1.6 percent. Meanwhile, a supply shock made it challenging for the nation to get medical raw materials (BBO) since imports met 90% of BBO requirements.…
1 July 2022

Actively Contributing to Overcoming Health Problems, Dexa Group Wins Indonesia Best CSR Award 2022

Dexa Group received the Outstanding Program in Prioritizing Public Health Needs award from Warta Ekonomi's Indonesia Best CSR Award 2022 for its contribution to the healthcare industry. This honor is granted in recognition of Dexa Group's significant work putting social responsibility and environmental responsibility initiatives into action. On Thursday, June…
25 June 2022

The 'Bangga Buatan Indonesia' Movement Promotes Pharmacy Product Independence

Dexa Group participated in the Proudly Made in Indonesia 2022 event once more to accelerate the independence of domestic local products. On Thursday, June 23, 2022, the Bangga Buatan Indonesia (BBI) event with the title Lagawi Fest (Lampung Bangga Wirausaha Industri Festival) Satu Bumi Juta Karya was held on Tegal…
20 May 2022

Dexa Group Wins IMACO Awards 2022 for Consistently Developing Indonesian Indigenous Modern Medicines Product Innovations

Dexa Group, was named the Indonesia Most Acclaimed Company (IMACO) 2022 in the Healthcare Industry category for Outstanding Corporate Strategy for Innovative Business by Warta Ekonomi. This award validates Dexa Group's commitment as a national pharmaceutical company to continue innovating via competitive product research and development to achieve pharmaceutical independence.…
28 January 2022

Dexa Group Wins the Indonesia Corporate Public Relations Award for the 4th time

Dexa Group was awarded The Best Indonesia Public Relations Award in the Pharmaceutical Category by the Indonesia Corporate Public Relations Award (IPRA) 2022 for its performance in Corporate Public Relations. Dexa Group has won the IPRA Award for the fourth time since 2018. With the theme "Creating Impact for a…
26 January 2021

Dexa Group Scoops Indonesia Public Relations Award 2021

Dexa Group received another award for its Corporate Public Relations performance at the Indonesia Corporate PR Award (IPRA) 2020 in The Best Public Relations in Healthcare & Pharmaceuticals category. This is the third IPRA award Dexa Group has collected since 2018. This award was presented virtually by the CEO of…
18 December 2020

Dexa Group CEO Named as Most Admired CEO 2020 for Ensuring Innovation in the Midst of Crisis

Dexa Group CEO, Ferry Soetikno won the Most Admired CEO 2020 award themed “The Rise of New Leadership Era to Accelerate Recovery” in the category of Outstanding Leadership for World-Class Pharmaceutical Company in Developing Health Sector Innovation to Survive During Crisis from WartaEkonomi.co.id Research and Consulting. This award applauds the…